Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · see citing works

Global quantification of mammalian gene expression control

Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · see citing works

Direct Gene Transfer into Mouse Muscle in Vivo

Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · see citing works

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947 · see citing works

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444 · see citing works

Non-viral vectors for gene-based therapy

Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123 · see citing works

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728 · see citing works

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA

Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · see citing works

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works

Production of recombinant protein therapeutics in cultivated mammalian cells

Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · see citing works

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930 · see citing works

Protein Therapeutics: A Summary and Pharmacological Classification

Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 1,913 · see citing works

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins

Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788 · see citing works

Induced pluripotent stem cells generated without viral integration

Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008) · Science · doi:10.1126/science.1162494 · Cited by 1,683 · see citing works

Synonymous but not the same: the causes and consequences of codon bias

Plotkin, J. B., & Kudla, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2899 · Cited by 1,677 · see citing works

Growth factor delivery-based tissue engineering: general approaches and a review of recent developments

Lee, K., Silva, E. A., & Mooney, D. J. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2010.0223 · Cited by 1,393 · see citing works

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

Li, Q., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,353 · see citing works

At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells

Kozak, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90418-9 · Cited by 1,182 · see citing works

Leukocyte Migration into Inflamed Tissues

Nourshargh, S., & Alon, R. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.008 · Cited by 1,172 · see citing works

Heart repair by reprogramming non-myocytes with cardiac transcription factors

Song, K., Nam, Y., Luo, X., Qi, X., Tan, W. H., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,141 · see citing works

Protein drug stability: a formulation challenge

Frøkjær, S., & Otzen, D. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1695 · Cited by 1,102 · see citing works

mRNA is an endogenous ligand for toll-like receptor 3

Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062 · see citing works

Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies

Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022 · see citing works

Untranslated regions of mRNAs.

(2002) · Genome biology · doi:10.1186/gb-2002-3-3-reviews0004 · Cited by 987 · see citing works

Regenerative medicine: Current therapies and future directions

Mao, A. S., & Mooney, D. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508520112 · Cited by 960 · see citing works

Modified mRNA vaccines protect against zika virus infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909 · see citing works

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA

Karikó, K., Muramatsu, H., Ludwig, J., & Weissman, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr695 · Cited by 898 · see citing works

mRNA capping: biological functions and applications

Ramanathan, A., Robb, G. B., & Chan, S. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw551 · Cited by 892 · see citing works

Therapeutic antibodies for autoimmunity and inflammation

Chan, A. C., & Carter, P. J. (2010) · Nature reviews. Immunology · doi:10.1038/nri2761 · Cited by 840 · see citing works

A decade of transcription factor-mediated reprogramming to pluripotency

Takahashi, K., & Yamanaka, S. (2016) · Nature reviews. Molecular cell biology · doi:10.1038/nrm.2016.8 · Cited by 815 · see citing works

Basics and Recent Advances in Peptide and Protein Drug Delivery

Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 760 · see citing works

Expression of therapeutic proteins after delivery of chemically modified mRNA in mice

Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733 · see citing works

Improvement in outcomes of clinical islet transplantation: 1999–2010

Barton, F. B., Rickels, M. R., Alejandro, R., Hering, B. J., Wease, S., Naziruddin, B., Oberholzer, J., Odorico, J. S., Garfinkel, M. R., Levy, M., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0063 · Cited by 725 · see citing works

Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration

Jopling, C., Boué, S., & Belmonte, J. C. I. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3043 · Cited by 724 · see citing works

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy

Oberli, M. A., Reichmuth, A. M., Dorkin, J. R., Mitchell, M. J., Fenton, O. S., Jaklenec, A., Anderson, D. G., Langer, R., & Blankschtein, D. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b03329 · Cited by 719 · see citing works

N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice

Andries, O., Mc Cafferty, S., De Smedt, S. C., Weiss, R., Sanders, N. N., & Kitada, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.051 · Cited by 701 · see citing works

Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples

Masuda, N., Ohnishi, T., Kawamoto, S., Monden, M., & Okubo, K. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.22.4436 · Cited by 683 · see citing works

Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq347 · Cited by 682 · see citing works

The mRNA 5′ cap-binding protein eIF4E and control of cell growth

Sonenberg, N., & Gingras, A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80150-6 · Cited by 673 · see citing works

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

Zangi, L., Lui, K. O., von Gise, A., Ma, Q., Ebina, W., Ptaszek, L. M., Später, D., Xu, H., Tabebordbar, M., Gorbatov, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2682 · Cited by 646 · see citing works

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells

Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625 · see citing works

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Honmou, O., Niitsu, Y., & Hamada, H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302276 · Cited by 597 · see citing works

Delivery technologies for genome editing

Yin, H., Kauffman, K. J., & Anderson, D. G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.280 · Cited by 597 · see citing works

Recognition of cap structure in splicing in vitro of mRNA precursors

Konarska, M. M., Padgett, R. A., & Sharp, P. A. (1984) · Cell · doi:10.1016/0092-8674(84)90268-x · Cited by 588 · see citing works

Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice

Rezania, A., Bruin, J. E., Riedel, M. J., Mojibian, M., Asadi, A., Xu, J., Gauvin, R., Narayan, K., Karanu, F., O’Neil, J. J., et al. (2012) · Diabetes · doi:10.2337/db11-1711 · Cited by 582 · see citing works

Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells

Rüster, B., Göttig, S., Ludwig, R. J., Bistrian, R., Müller, S., Seifried, E., Gille, J., & Henschler, R. (2006) · Blood · doi:10.1182/blood-2006-05-025098 · Cited by 562 · see citing works

Nucleic-acid therapeutics: basic principles and recent applications

Opalinska, J., & Gewirtz, A. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd837 · Cited by 535 · see citing works

Essential Role for the dsRNA-Dependent Protein Kinase PKR in Innate Immunity to Viral Infection

Balachandran, S., Roberts, P. C., Brown, L. E., Truong, H., Pattnaik, A. K., Archer, D. R., & Barber, G. N. (2000) · Immunity · doi:10.1016/s1074-7613(00)00014-5 · Cited by 527 · see citing works

Characterization and Functionality of Cell Surface Molecules on Human Mesenchymal Stem Cells

Majumdar, M. K., Keane-Moore, M., Buyaner, D., Hardy, W., Moorman, M. A., McIntosh, K. R., & Mosca, J. D. (2003) · Journal of Biomedical Science · doi:10.1007/bf02256058 · Cited by 527 · see citing works

Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms

Kahvejian, A., Svitkin, Y. V., Sukarieh, R., M'Boutchou, M.-N., & Sonenberg, N. (2005) · Genes & Development · doi:10.1101/gad.1262905 · Cited by 491 · see citing works

Molecular basis of double‐stranded RNA‐protein interactions: structure of a dsRNA‐binding domain complexed with dsRNA

Ryter, J. M., & Schultz, S. C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7505 · Cited by 479 · see citing works

5'-terminal cap structure in eucaryotic messenger ribonucleic acids

Banerjee, A. K. (1980) · Microbiological Reviews · doi:10.1128/mr.44.2.175-205.1980 · Cited by 477 · see citing works

Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor

Zhao, Y., Moon, E. K., Carpenito, C., Paulos, C. M., Liu, X., Brennan, A. L., Chew, A., Carroll, R. G., Scholler, J., Levine, B. L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2880 · Cited by 448 · see citing works

Targeted Migration of Mesenchymal Stem Cells Modified With CXCR4 Gene to Infarcted Myocardium Improves Cardiac Performance

Cheng, Z., Ou, L., Zhou, X., Li, F., Jia, X., Zhang, Y., Liu, X., Li, Y., Ward, C. A., Melo, L. G., et al. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300374 · Cited by 440 · see citing works

Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial

Alton, E. W. F. W., Stern, M., Farley, R., Jaffé, A., Chadwick, S., Phillips, J., Davies, J. C., Smith, S. N., Browning, J. A., Davies, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06532-5 · Cited by 434 · see citing works

Cellular IRES-mediated translation

Komar, A. A., & Hatzoglou, M. (2011) · Cell Cycle · doi:10.4161/cc.10.2.14472 · Cited by 418 · see citing works

Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.

Elroy‐Stein, O., Fuerst, T. R., & Moss, B. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6126 · Cited by 405 · see citing works

Getting Leukocytes to the Site of Inflammation

Müller, W. A. (2013) · Veterinary Pathology · doi:10.1177/0300985812469883 · Cited by 401 · see citing works

Gene therapy progress and prospects: non-viral gene therapy by systemic delivery

Li, S.-D., & Huang, L. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302838 · Cited by 392 · see citing works

Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems

Guan, S., & Rosenecker, J. (2017) · Gene Therapy · doi:10.1038/gt.2017.5 · Cited by 389 · see citing works

Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor

Wood, A. J. J., Lieschke, G. J., & Burgess, A. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270207 · Cited by 373 · see citing works

XRN 5′→3′ exoribonucleases: Structure, mechanisms and functions

Nagarajan, V. K., Jones, C. I., Newbury, S. F., & Green, P. J. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.03.005 · Cited by 366 · see citing works

The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells.

Matoulkova, E., Michalova, E., Vojtesek, B., & Hrstka, R. (2012) · RNA Biology · doi:10.4161/rna.20231 · Cited by 357 · see citing works

Untitled work

(2001) · PubMed Central · Cited by 342 · see citing works

Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals

Chamary, J., & Hurst, L. D. (2005) · Genome biology · doi:10.1186/gb-2005-6-9-r75 · Cited by 332 · see citing works

Advances in Non-Viral DNA Vectors for Gene Therapy

Hardee, C. L., Arévalo-Soliz, L., Hornstein, B. D., & Zechiedrich, L. (2017) · Genes · doi:10.3390/genes8020065 · Cited by 329 · see citing works

Reprogramming Factor Stoichiometry Influences the Epigenetic State and Biological Properties of Induced Pluripotent Stem Cells

Carey, B. W., Markoulaki, S., Hanna, J. H., Faddah, D. A., Buganim, Y., Kim, J., Ganz, K., Steine, E. J., Cassady, J. P., Creyghton, M. P., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.11.003 · Cited by 326 · see citing works

Efficient generation of human iPSCs by a synthetic self-replicative RNA

Yoshioka, N., Gros, E., Li, H.-R., Kumar, S., Deacon, D. C., Maron, C., Muotri, A. R., Chi, N. C., Fu, X.-D., Yu, B. D., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.001 · Cited by 312 · see citing works

Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity

Kreiter, S., Selmi, A., Diken, M., Koslowski, M., Britten, C. M., Huber, C., Türeci, Ö., & Sahin, U. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0699 · Cited by 309 · see citing works

Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin

Karikó, K., Muramatsu, H., Keller, J. M., & Weissman, D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.7 · Cited by 282 · see citing works

Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides

Diebold, S. S., Massacrier, C., Akira, S., Paturel, C., Morel, Y., & Sousa, C. R. E. (2006) · European Journal of Immunology · doi:10.1002/eji.200636617 · Cited by 281 · see citing works

Genetic Disorders of Surfactant Dysfunction

Wert, S. E., Whitsett, J. A., & Nogee, L. M. (2009) · Pediatric and Developmental Pathology · doi:10.2350/09-01-0586.1 · Cited by 280 · see citing works

Regulation of liver regeneration by growth factors and cytokines

Böhm, F., Köhler, U. A., Speicher, T., & Werner, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000085 · Cited by 275 · see citing works

The identity of the base following the stop codon determines the efficiency of in vivo translational termination in Escherichia coli.

Poole, E. S., Brown, C. M., & Tate, W. P. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb06985.x · Cited by 267 · see citing works

The scavenger mRNA decapping enzyme DcpS is a member of the HIT family of pyrophosphatases

Liu, H., Rodgers, N. D., Jiao, X., & Kiledjian, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf448 · Cited by 267 · see citing works

SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model

Wang, Y., Deng, Y., & Zhou, G. (2008) · Brain Research · doi:10.1016/j.brainres.2007.11.068 · Cited by 266 · see citing works

Novel “anti-reverse” cap analogs with superior translational properties

Jemielity, J., Fowler, T. E., Zuberek, J., Stȩpiński, J., Lewdorowicz, M., Niedźwiecka-Kornaś, A., Stolarski, R., Darżynkiewicz, E., & Rhoads, R. E. (2003) · RNA · doi:10.1261/rna.5430403 · Cited by 263 · see citing works

An mRNA Stability Complex Functions with Poly(A)-Binding Protein To Stabilize mRNA In Vitro

Wang, Z., Day, N., Trifillis, P., & Kiledjian, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4552 · Cited by 262 · see citing works

Engineering mesenchymal stem cells for regenerative medicine and drug delivery

Park, J. S., Suryaprakash, S., Lao, Y., & Leong, K. W. (2015) · Methods · doi:10.1016/j.ymeth.2015.03.002 · Cited by 242 · see citing works

Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors

Yakubov, E., Rechavi, G., Rozenblatt, S., & Givol, D. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.150 · Cited by 240 · see citing works

Non-viral gene therapy: Gains and challenges of non-invasive administration methods

Földvári, M., Chen, D.-W., Nafissi, N., Calderon-Nieva, D., Narsineni, L., & Rafiee, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.012 · Cited by 240 · see citing works

Characterization of CD4+ T Cell Responses During Natural Infection with Salmonella typhimurium

McSorley, S. J., Cookson, B. T., & Jenkins, M. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.986 · Cited by 239 · see citing works

Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells

Steingen, C., Brenig, F., Baumgartner, L., Schmidt, J., Schmidt, A., & Bloch, W. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.010 · Cited by 233 · see citing works

Polycistronic Lentiviral Vector for “Hit and Run” Reprogramming of Adult Skin Fibroblasts to Induced Pluripotent Stem Cells

Chang, C.-W., Lai, Y.-S., Pawlik, K. M., Liu, K.-M., Sun, C.-W., Li, C., Schoeb, T., & Townes, T. (2009) · Stem Cells · doi:10.1002/stem.39 · Cited by 229 · see citing works

Inefficient Reprogramming of Fibroblasts into Cardiomyocytes Using Gata4, Mef2c, and Tbx5

Chen, J., Krane, M., Deutsch, M.-A., Wang, L., Rav-Acha, M., Grégoire, S., Engels, M. C., Rajarajan, K., Karra, R., Abel, E. D., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.270264 · Cited by 228 · see citing works

Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo

Kuhn, A. N., Diken, M., Kreiter, S., Selmi, A., Kowalska, J., Jemielity, J., Darzynkiewicz, E., Huber, C., Türeci, Ö., & Sahin, U. (2010) · Gene Therapy · doi:10.1038/gt.2010.52 · Cited by 226 · see citing works

Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals

Kreiter, S., Selmi, A., Diken, M., Sebastian, M., Osterloh, P., Schild, H., Huber, C., Türeci, Ö., & Şahin, U. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.309 · Cited by 221 · see citing works

Modified mRNA Vaccines Protect against Zika Virus Infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.016 · Cited by 221 · see citing works

Induced Pluripotent Stem Cells: Problems and Advantages when Applying them in Regenerative Medicine

Medvedev, S., Shevchenko, A. I., & Zakian, S. (2010) · Acta Naturae · doi:10.32607/20758251-2010-2-2-18-27 · Cited by 220 · see citing works

mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation

Levy, O., Zhao, W., Mortensen, L. J., LeBlanc, S., Tsang, K., Fu, M., Phillips, J. A., Sagar, V., Anandakumaran, P. N., Ngai, J., et al. (2013) · Blood · doi:10.1182/blood-2013-04-495119 · Cited by 212 · see citing works

Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity

Barral, P. M., Sarkar, D., Su, Z.-Z., Barber, G. N., DeSalle, R., Racaniello, V. R., & Fisher, P. B. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.012 · Cited by 200 · see citing works

Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow

Xia, L., McDaniel, J. M., Yago, T., Doeden, A., & McEver, R. P. (2004) · Blood · doi:10.1182/blood-2004-02-0650 · Cited by 199 · see citing works

Comprehensive Analysis of Chemotactic Factors for Bone Marrow Mesenchymal Stem Cells

Ozaki, Y., Nishimura, M., Sekiya, K., Suehiro, F., Kanawa, M., Nikawa, H., Hamada, T., & Kato, Y. (2007) · Stem Cells and Development · doi:10.1089/scd.2006.0032 · Cited by 198 · see citing works

Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo

Kauffman, K. J., Mir, F. F., Jhunjhunwala, S., Kaczmarek, J. C., Hurtado, J. E., Yang, J. H., Webber, M. J., Kowalski, P. S., Heartlein, M. W., DeRosa, F., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.006 · Cited by 191 · see citing works

Systematic discovery of structural elements governing stability of mammalian messenger RNAs

Goodarzi, H., Najafabadi, H. S., Oikonomou, P., Greco, T. M., Fish, L., Salavati, R., Cristea, I. M., & Tavazoie, S. (2012) · Nature · doi:10.1038/nature11013 · Cited by 187 · see citing works

Engineering of Therapeutic Proteins Production in Escherichia coli

Kamionka, M. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794295693 · Cited by 177 · see citing works

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Zhang, M., Lin, Y.-H., Sun, Y. J., Zhu, S., Zheng, J., Liu, K., Cao, N., Li, K., Huang, Y., & Ding, S. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.03.020 · Cited by 176 · see citing works

High affinity interaction of integrin α4β1 (VLA‐4) and vascular cell adhesion molecule 1 (VCAM‐1) enhances migration of human melanoma cells across activated endothelial cell layers

Klemke, M., Weschenfelder, T., Konstandin, M. H., & Samstag, Y. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21029 · Cited by 167 · see citing works

mRNA transfection of dendritic cells: Synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level

Mockey, M., Gonçalves, C., Dupuy, F. P., Lemoine, F. M., Pichon, C., & Midoux, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.105 · Cited by 165 · see citing works

Rapid Conversion of Fibroblasts into Functional Forebrain GABAergic Interneurons by Direct Genetic Reprogramming

Colasante, G., Lignani, G., Rubio, A., Medrihan, L., Yekhlef, L., Sessa, A., Massimino, L., Giannelli, S. G., Sacchetti, S., Caiazzo, M., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.09.002 · Cited by 165 · see citing works

Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells

Scholten, K. B. J., Kramer, D., Taanman-Kueter, E. W., Graf, M., Schoedl, T., Meijer, C. J. L. M., Schreurs, M. W. J., & Hooijberg, E. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.12.009 · Cited by 164 · see citing works

Recombinant therapeutic proteins: Production platforms and challenges

Dingermann, T. (2007) · Biotechnology Journal · doi:10.1002/biot.200700214 · Cited by 164 · see citing works

Clinical efficacy of becaplermin (rhPDGF-BB) gel

Wieman, T. J. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00185-8 · Cited by 162 · see citing works

Recombinant human platelet‐derived growth factor‐BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open‐label clinical evaluation of efficacy

Embil, J. M., Papp, K. A., Sibbald, G. R., Tousignant, J., Smiell, J. M., Wong, B. Y. L., Lau, C., & THE CANADIAN BECAPLERMIN STUDY GROUP (2000) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2000.00162.x · Cited by 161 · see citing works

Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system

DeRosa, F., Guild, B., Karve, S., Smith, L., Love, K., Dorkin, J. R., Kauffman, K. J., Zhang, J., Yahalom, B., Anderson, D. G., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.46 · Cited by 159 · see citing works

[4] Synthesis of long, capped transcripts in Vitro by SP6 and T7 RNA polymerases

Yisraeli, J. K., & Melton, D. A. (1989) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(89)80090-4 · Cited by 156 · see citing works

Effects of Chemically Modified Messenger RNA on Protein Expression

Li, B., Luo, X. L., & Dong, Y. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00090 · Cited by 154 · see citing works

Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells

Grudzien‐Nogalska, E., Jemielity, J., Kowalska, J., Darżynkiewicz, E., & Rhoads, R. E. (2007) · RNA · doi:10.1261/rna.701307 · Cited by 152 · see citing works

Gene Therapy of Intracranial Glioma Using Interleukin 12–Secreting Human Umbilical Cord Blood–Derived Mesenchymal Stem Cells

Ryu, C. H., Park, S., Park, S. A., Kim, S. M., Lim, J. Y., Jeong, C. H., Yoon, W., Oh, W., Sung, Y. C., & Jeun, S. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.187 · Cited by 151 · see citing works

Reverse 5' caps in RNAs made in vitro by phage RNA polymerases.

Pasquinelli, A. E., Dahlberg, J. E., & Lund, E. (1995) · PubMed · Cited by 148 · see citing works

Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine

Nakanishi, M., & Otsu, M. (2012) · Current Gene Therapy · doi:10.2174/156652312802762518 · Cited by 147 · see citing works

Regulation of mRNA decapping

Li, Y., & Kiledjian, M. (2010) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.15 · Cited by 145 · see citing works

Rapid, nondenaturing RNA purification using weak anion-exchange fast performance liquid chromatography

Easton, L. E., Shibata, Y., & Lukavsky, P. J. (2010) · RNA · doi:10.1261/rna.1862210 · Cited by 143 · see citing works

Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich’s ataxia

Nabhan, J. F., Wood, K. M., Rao, V. P., Morin, J., Bhamidipaty, S., LaBranche, T. P., Gooch, R. L., Bozal, F., Bulawa, C. E., & Guild, B. C. (2016) · Scientific Reports · doi:10.1038/srep20019 · Cited by 140 · see citing works

Function and Regulation of Retinoic Acid-Inducible Gene-I

Matsumiya, T., & Stafforini, D. M. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i6.10 · Cited by 139 · see citing works

Cap-Independent Translation Conferred by the 5′ Leader of Tobacco Etch Virus Is Eukaryotic Initiation Factor 4G Dependent

Gallie, D. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12141-12152.2001 · Cited by 134 · see citing works

Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model

Kyriakou, C. A., Rabin, N. K., Pizzey, A. R., Nathwani, A. C., & Yong, K. (2008) · Haematologica · doi:10.3324/haematol.12553 · Cited by 130 · see citing works

Decoying the Cap 2 mRNA Degradation System by a Double-Stranded RNA Virus and Poly(A) 2 mRNA Surveillance by a Yeast Antiviral System

Masison, D. C., Blanc, A., Ribas, J. C., Carroll, K., Sonenberg, N., & Wickner, R. B. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2763 · Cited by 128 · see citing works

Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model

Ling, X., Marini, F. C., Konopleva, M. Y., Schober, W. D., Shi, Y., Burks, J. K., Clise-Dwyer, K., Wang, R., Zhang, W., Yuan, X., et al. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0041-8 · Cited by 122 · see citing works

Protein Therapeutics for Cardiac Regeneration after Myocardial Infarction

Segers, V. F. M., & Lee, R. T. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9207-5 · Cited by 121 · see citing works

A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs

Kallen, K., & Theß, A. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613508729 · Cited by 120 · see citing works

Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy

Zaruba, M., & Franz, W. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903460286 · Cited by 119 · see citing works

Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafA

Akıncı, E., Banga, A., Greder, L. V., Dutton, J. R., & Slack, J. M. W. (2011) · Biochemical Journal · doi:10.1042/bj20111678 · Cited by 115 · see citing works

Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy

Youn, H., & Chung, J.-K. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1057563 · Cited by 114 · see citing works

Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells

Choi, H. Y., Lee, T., Yang, G., Oh, J., Won, J., Han, J., Jeong, G., Kim, J., Kim, J., Kim, B., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.007 · Cited by 114 · see citing works

Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism

Mays, L. E., Ammon-Treiber, S., Mothes, B., Alkhaled, M., Rottenberger, J., Müller-Hermelink, E. S., Grimm, M., Mezger, M., Beer-Hammer, S., von Stebut, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65351 · Cited by 113 · see citing works

RNA Mediated toll-like receptor stimulation in health and disease

Dalpke, A. H., & Helm, M. (2012) · RNA Biology · doi:10.4161/rna.20206 · Cited by 113 · see citing works

Structural and biochemical studies of the 5′→3′ exoribonuclease Xrn1

Chang, J. H., Xiang, S., Xiang, K., Manley, J. L., & Tong, L. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1984 · Cited by 113 · see citing works

The Poly(A)-Binding Protein and an mRNA Stability Protein Jointly Regulate an Endoribonuclease Activity

Wang, Z., & Kiledjian, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.17.6334-6341.2000 · Cited by 113 · see citing works

Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles

Lin, C., Perche, F., Ikegami, M., Uchida, S., Kataoka, K., & Itaka, K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.001 · Cited by 113 · see citing works

Cardiac regeneration: current therapies-future concepts.

Doppler, S. A., Deutsch, M.-A., Lange, R., & Krane, M. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.08.71 · Cited by 110 · see citing works

The CCR2/CCL2 Interaction Mediates the Transendothelial Recruitment of Intravascularly Delivered Neural Stem Cells to the Ischemic Brain

Andres, R. H., Choi, R., Pendharkar, A. V., Gaeta, X., Wang, N. N., Nathan, J. K., Chua, J. Y., Lee, S. W., Palmer, T. D., Steinberg, G. K., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.606368 · Cited by 106 · see citing works

Adenoviral‐mediated interleukin‐18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats

Xu, G., Jiang, X., Xu, Y., Zhang, J., Huang, F., Chen, Z., Zhou, D., Shang, J., Zou, Y., Cai, Y., et al. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.07.023 · Cited by 105 · see citing works

A Nucleolin-Binding 3′ Untranslated Region Element Stabilizes β-Globin mRNA In Vivo

Jiang, Y., Xu, X.-S., & Russell, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2419-2429.2006 · Cited by 103 · see citing works

Functions of the 5′‐terminal m7G cap in eukaryotic mRNA

Filipowicz, W. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)81049-7 · Cited by 102 · see citing works

Denaturing Urea Polyacrylamide Gel Electrophoresis (Urea PAGE)

Summer, H., Grämer, R., & Dröge, P. (2009) · Journal of Visualized Experiments · doi:10.3791/1485 · Cited by 102 · see citing works

Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis

Liao, W., Pham, V., Liu, L., Riazifar, M., Pone, E. J., Zhang, S. X., Ma, F., Lu, M., Walsh, C. M., & Zhao, W. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.005 · Cited by 102 · see citing works

Restoration of Bone Mass and Strength in Glucocorticoid-Treated Mice by Systemic Transplantation of CXCR4 and Cbfa-1 Co-Expressing Mesenchymal Stem Cells

Lien, C.-Y., Ho, K., Lee, O. K., Blunn, G. W., & Su, Y. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081257 · Cited by 100 · see citing works

TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo

Mueller, L. P., Luetzkendorf, J., Widder, M., Nerger, K., Caysa, H., & Mueller, T. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.68 · Cited by 99 · see citing works

mRNA-based gene transfer as a tool for gene and cell therapy.

Tendeloo, V. F. V., Ponsaerts, P., & Berneman, Z. N. (2007) · PubMed · Cited by 98 · see citing works

Purification and characterization of transcribed RNAs using gel filtration chromatography

McKenna, S. A., Kim, I., Puglisi, E. V., Lindhout, D. A., Aitken, C. E., Marshall, R. A., & Puglisi, J. D. (2007) · Nature Protocols · doi:10.1038/nprot.2007.480 · Cited by 98 · see citing works

Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise

Duelen, R., & Sampaolesi, M. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.029 · Cited by 96 · see citing works

Differential Inhibition of mRNA Degradation Pathways by Novel Cap Analogs

Grudzien, E., Kalek, M., Jemielity, J., Darzynkiewicz, E., & Rhoads, R. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509121200 · Cited by 90 · see citing works

Structural and Functional Analysis of an mRNP Complex That Mediates the High Stability of Human β-Globin mRNA

Yu, J., & Russell, J. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5879-5888.2001 · Cited by 90 · see citing works

Oligodeoxynucleotides Differentially Modulate Activation of TLR7 and TLR8 by Imidazoquinolines

Gorden, K. B., Qiu, X., Battiste, J. L., Wightman, P. D., Vasilakos, J. P., & Alkan, Ş. Ş. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8164 · Cited by 90 · see citing works

Screening of mRNA Chemical Modification to Maximize Protein Expression with Reduced Immunogenicity

Uchida, S., Kataoka, K., & Itaka, K. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7030137 · Cited by 88 · see citing works

MSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimine

Moon, H.-H., Joo, M. K., Mok, H., Lee, M., Hwang, K.-C., Kim, S. W., Jeong, J. H., Choi, D., & Kim, S. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.019 · Cited by 84 · see citing works

Dedifferentiation, Transdifferentiation, and Reprogramming: Future Directions in Regenerative Medicine

Eguizábal, C., Montserrat, N., Veiga, A., & Belmonte, J. C. I. (2013) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1331802 · Cited by 83 · see citing works

Apoptosis and the cardiac action of insulin-like growth factor I.

Suleiman, M., Singh, R., & Stewart, C. (2007) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2007.03.001 · Cited by 82 · see citing works

A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-9

Khorsand, B., Elangovan, S., Hong, L., Dewerth, A., Kormann, M., & Salem, A. K. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0034-8 · Cited by 82 · see citing works

Myotonic Dystrophy: The Role of RNA CUG Triplet Repeats

Timchenko, L. (1999) · The American Journal of Human Genetics · doi:10.1086/302268 · Cited by 81 · see citing works

Regeneration of bone using nanoplex delivery of FGF-2 and BMP-2 genes in diaphyseal long bone radial defects in a diabetic rabbit model

Khorsand, B., Nicholson, N., Do, A., Femino, J. E., Martin, J. A., Petersen, E. B., Guetschow, B., Fredericks, D. C., & Salem, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.008 · Cited by 81 · see citing works

Characterization of Coding Synonymous and Non-Synonymous Variants in ADAMTS13 Using Ex Vivo and In Silico Approaches

Edwards, N. C., Hing, Z. A., Perry, A., Blaisdell, A., Kopelman, D., Fathke, R. L., Plum, W. G., Newell, J. M., Allen, C. E., Geetha, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038864 · Cited by 80 · see citing works

Synthesis and Application of a Chain-Terminating Dinucleotide mRNA Cap Analog

Peng, Z., Sharma, V., Singleton, S. F., & Gershon, P. D. (2001) · Organic Letters · doi:10.1021/ol0167715 · Cited by 80 · see citing works

Targeted delivery of progenitor cells for cartilage repair

Dennis, J. E., Cohen, N., Goldberg, V. M., & Caplan, A. I. (2004) · Journal of Orthopaedic Research® · doi:10.1016/j.orthres.2003.12.002 · Cited by 80 · see citing works

Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells

Bontkes, H. J., Kramer, D., Ruizendaal, J. J., Taanman-Kueter, E. W., Tendeloo, V. F. V., Meijer, C. J. L. M., & Hooijberg, E. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302874 · Cited by 80 · see citing works

Characterization of T‐cell immune responses of Echinococcus multilocularis‐infected C57BL/6J mice

Emery, I., Liance, M., Dériaud, E., Vuitton, D. A., Houin, R., & Leclerc, C. (1996) · Parasite Immunology · doi:10.1111/j.1365-3024.1996.tb01030.x · Cited by 80 · see citing works

Transcript-activated collagen matrix as sustained mRNA delivery system for bone regeneration

Badieyan, Z. S., Berezhanskyy, T., Utzinger, M., Aneja, M. K., Emrich, D., Erben, R. G., Schüler, C., Altpeter, P., Ferizi, M., Hasenpusch, G., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.037 · Cited by 80 · see citing works

Virus-inspired nucleic acid delivery system: Linking virus and viral mimicry

Ni, R., Zhou, J., Hossain, N., & Chau, Y. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.005 · Cited by 78 · see citing works

Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges

Steinle, H., Behring, A., Schlensak, C., Wendel, H. P., & Avci‐Adali, M. (2016) · Stem Cells · doi:10.1002/stem.2402 · Cited by 78 · see citing works

Expression of human nephrin mRNA in diabetic nephropathy

Toyoda, M. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg545 · Cited by 77 · see citing works

Analysis of oligonucleotide AUG start codon context in eukariotic mRNAs

Pesole, G., Gissi, C., Grillo, G., Licciulli, F., Liuni, S., & Saccone, C. (2000) · Gene · doi:10.1016/s0378-1119(00)00471-6 · Cited by 74 · see citing works

Recent Advances in Developing Small Molecules Targeting Nucleic Acid

Wang, M., Yu, Y., Liang, C., Lü, A., & Zhang, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060779 · Cited by 74 · see citing works

Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond

Vallazza, B., Petri, S., Poleganov, M. A., Eberle, F., Kuhn, A. N., & Şahin, U. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1288 · Cited by 73 · see citing works

Synthetic Messenger RNA as a Tool for Gene Therapy

Rabinovich, P. M., Komarovskaya, M., Ye, Z.-J., Imai, C., Campana, D., Bahceci, E., & Weissman, S. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1027 · Cited by 73 · see citing works

Effective delivery with enhanced translational activity synergistically accelerates mRNA-based transfection

Zohra, F. T., Chowdhury, E. H., Tada, S., Hoshiba, T., & Akaike, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.059 · Cited by 71 · see citing works

UU/UA Dinucleotide Frequency Reduction in Coding Regions Results in Increased mRNA Stability and Protein Expression

Al‐Saif, M., & Khabar, K. S. A. (2012) · Molecular Therapy · doi:10.1038/mt.2012.29 · Cited by 69 · see citing works

Non-viral nucleic acid delivery methods

Slivac, I., Guay, D. R. P., Mangion, M., Champeil, J., & Gaillet, B. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1248941 · Cited by 68 · see citing works

Cystic fibrosis transmembrane conductance regulator‐mRNA delivery: a novel alternative for cystic fibrosis gene therapy

Bangel‐Ruland, N., Tomczak, K., Fernández, E. F., Leier, G., Leciejewski, B., Rudolph, C., Rosenecker, J., & Weber, W. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2748 · Cited by 67 · see citing works

Synthetic Chemically Modified mRNA-Based Delivery of Cytoprotective Factor Promotes Early Cardiomyocyte Survival Post-Acute Myocardial Infarction

Huang, C., Leblond, A., Turner, E. C., Kumar, A. H. S., Martin, K., Whelan, D., O’Sullivan, D. M., & Caplice, N. M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5006239 · Cited by 66 · see citing works

Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins

Gulck, E. R. A. V. (2005) · Blood · doi:10.1182/blood-2005-01-0339 · Cited by 63 · see citing works

Non-Viral Methods For Generating Integration-Free, Induced Pluripotent Stem Cells

Deng, X., Wang, H., Wang, T., Fang, X.-T., Zou, L., Li, Z., & Liu, C.-B. (2015) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666140923101914 · Cited by 62 · see citing works

Modified mRNA for BMP-2 in Combination with Biomaterials Serves as a Transcript-Activated Matrix for Effectively Inducing Osteogenic Pathways in Stem Cells

Balmayor, E. R., Geiger, J. P., Koch, C., Aneja, M. K., van Griensven, M., Rudolph, C., & Plank, C. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0171 · Cited by 62 · see citing works

Neural Stem Cells Differentiated From iPS Cells Spontaneously Regain Pluripotency

Choi, H. W., Kim, J. S., Choi, S., Hong, Y. J., Kim, M. J., Seo, H. G., & Tae, J. (2014) · Stem Cells · doi:10.1002/stem.1757 · Cited by 61 · see citing works

Polysaccharide Multilayer Nanoencapsulation of Insulin-Producing β-Cells Grown as Pseudoislets for Potential Cellular Delivery of Insulin

Zhi, Z., Liu, B., Jones, P. M., & Pickup, J. C. (2010) · Biomacromolecules · doi:10.1021/bm901152k · Cited by 61 · see citing works

The Pharmacology of Regenerative Medicine

Christ, G. J., Saul, J. M., Furth, M. E., & Andersson, K. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007393 · Cited by 61 · see citing works

Improved Methods to Produce Tissue-Engineered Skin Substitutes Suitable for the Permanent Closure of Full-Thickness Skin Injuries

Larouche, D., Cantin-Warren, L., Desgagné, M., Guignard, R., Martel, I., Ayoub, A., Lavoie, A., Gauvin, R., Auger, F. A., Moulin, V. J., et al. (2016) · BioResearch open access · doi:10.1089/biores.2016.0036 · Cited by 61 · see citing works

Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion

Tcherepanova, I. Y., Adams, M. D., Feng, X., Hinohara, A., Horvatinovich, J. M., Calderhead, D. M., Healey, D. G., & Nicolette, C. A. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-90 · Cited by 60 · see citing works

Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety—fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis

Rydzik, A. M., Kulis, M., Łukaszewicz, M., Kowalska, J., Zuberek, J., Darżynkiewicz, Z. M., Darżynkiewicz, E., & Jemielity, J. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.01.013 · Cited by 59 · see citing works

Preparation of Chemically Modified RNA Origami Nanostructures

Endo, M., Takeuchi, Y., Emura, T., Hidaka, K., & Sugiyama, H. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201404084 · Cited by 58 · see citing works

Applications of Phosphate Modification and Labeling to Study (m)RNA Caps

Warmiński, M., Sikorski, P. J., Kowalska, J., & Jemielity, J. (2017) · Topics in Current Chemistry · doi:10.1007/s41061-017-0106-y · Cited by 57 · see citing works

Characterization of T Cell Responses to Fragrances

Sieben, S., Hertl, M., Masaoudi, T. A., Merk, H. F., & Blömeke, B. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9125 · Cited by 55 · see citing works

Synthetic dinucleotide mRNA cap analogs with tetraphosphate 5′,5′ bridge containing methylenebis(phosphonate) modification

Rydzik, A. M., Łukaszewicz, M., Zuberek, J., Kowalska, J., Darżynkiewicz, Z. M., Darżynkiewicz, E., & Jemielity, J. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b911347a · Cited by 55 · see citing works

Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells

Murthy, N., Lee, K., Yu, P., Lingampalli, N., Kim, H. J., & Tang, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s75124 · Cited by 53 · see citing works

Cell Replacement Strategies Aimed at Reconstitution of the β-Cell Compartment in Type 1 Diabetes

Orlando, G., Gianello, P., Salvatori, M., Stratta, R., Soker, S., Ricordi, C., & Domínguez-Bendala, J. (2014) · Diabetes · doi:10.2337/db13-1742 · Cited by 53 · see citing works

Structurally Distinct Requirements for Binding of P-selectin Glycoprotein Ligand-1 and Sialyl Lewis x to Anaplasma phagocytophilum and P-selectin

Yago, T., Leppänen, A., Carlyon, J. A., Akkoyunlu, M., Karmakar, S., Fikrig, E., Cummings, R. D., & McEver, R. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305778200 · Cited by 53 · see citing works

mRNA: A Versatile Molecule for Cancer Vaccines

Diken, M., Kranz, L. M., Kreiter, S., & Şahin, U. (2016) · Current Issues in Molecular Biology · doi:10.21775/cimb.022.113 · Cited by 52 · see citing works

Enzymatically stable 5′ mRNA cap analogs: Synthesis and binding studies with human DcpS decapping enzyme

Kałek, M., Jemielity, J., Darżynkiewicz, Z. M., Bojarska, E., Stȩpiński, J., Stolarski, R., Davis, R. E., & Darżynkiewicz, E. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.045 · Cited by 50 · see citing works

Self-assembled Messenger RNA Nanoparticles (mRNA-NPs) for Efficient Gene Expression

Kim, H., Park, Y., & Lee, J. B. (2015) · Scientific Reports · doi:10.1038/srep12737 · Cited by 50 · see citing works

Antisense ribosomes: rRNA as a vehicle for antisense RNAs.

Sweeney, R., Fan, Q., & Yao, M. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8518 · Cited by 49 · see citing works

Recent Trends in Drug Delivery System Using Protein Nanoparticles

Sripriyalakshmi, S., Jose, P., Ravindran, A., & Anjali, C. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9896-5 · Cited by 46 · see citing works

New strategies for improving stem cell therapy in ischemic heart disease

Huang, P., Tian, X., Li, Q., & Yang, Y. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9576-1 · Cited by 46 · see citing works

Design of an Optimized Wilms’ Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo

Benteyn, D., Anguille, S., Lint, S. V., Heirman, C., Nuffel, A. M. T. V., Corthals, J., Ochsenreither, S., Waelput, W., Beneden, K. V., Breckpot, K., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.54 · Cited by 44 · see citing works

Characterization of T Cell Responses to Hev b 3, an Allergen Associated with Latex Allergy in Spina Bifida Patients

Bohle, B., Wagner, B., Vollmann, U., Buck, D., Niggemann, B., Szépfalusi, Z., Fischer, G., Scheiner, O., Breiteneder, H., & Ebner, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4393 · Cited by 43 · see citing works

Therapeutic Modulation of Growth Factors and Cytokines in Regenerative Medicine

Ioannidou, E. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777699007 · Cited by 43 · see citing works

Strong anion-exchange fast performance liquid chromatography as a versatile tool for preparation and purification of RNA produced by in vitro transcription

Koubek, J., Lin, K. F., Chen, Y., Cheng, R. P., & Huang, J. J. (2013) · RNA · doi:10.1261/rna.038117.113 · Cited by 43 · see citing works

Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications

Strenkowska, M., Kowalska, J., Łukaszewicz, M., Zuberek, J., Su, W., Rhoads, R. E., Darżynkiewicz, E., & Jemielity, J. (2010) · New Journal of Chemistry · doi:10.1039/b9nj00644c · Cited by 42 · see citing works

Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage

Sridhar, A., Ohlemacher, S. K., Langer, K. B., & Meyer, J. S. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0093 · Cited by 42 · see citing works

Non‐Viral Co‐Delivery of the Four Yamanaka Factors for Generation of Human Induced Pluripotent Stem Cells via Calcium Phosphate Nanocomposite Particles

Cao, X., Deng, W., Qu, R., Yu, Q., Li, J., Yang, Y., Cao, Y., Gao, X., Xu, X., & Yu, J. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201203646 · Cited by 40 · see citing works

Enhanced non-viral gene delivery by coordinated endosomal release and inhibition of β-tubulin deactylase

Ho, Y. K., Zhou, L. H., Tam, K. C., & Too, H. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1143 · Cited by 40 · see citing works

mRNA-based therapeutics: powerful and versatile tools to combat diseases

Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 801 · see citing works

RNA-based therapeutics: an overview and prospectus

Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05075-2 · Cited by 658 · see citing works

Advances in COVID-19 mRNA vaccine development

Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601 · see citing works

mRNA vaccines manufacturing: challenges and bottlenecks

Rosa, S. S., Prazeres, D. M. F., Azevedo, A. M., & Marques, M. P. C. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.03.038 · Cited by 545 · see citing works

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers

Zhang, F., Parayath, N. N., Ene, C., Stephan, S. B., Koehne, A. L., Coon, M. E., Holland, E. C., & Stephan, M. T. (2019) · Nature Communications · doi:10.1038/s41467-019-11911-5 · Cited by 526 · see citing works

A Comprehensive Review of mRNA Vaccines

Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032700 · Cited by 457 · see citing works

An Update on Self-Amplifying mRNA Vaccine Development

Blakney, A. K., Ip, S., & Geall, A. J. (2021) · Vaccines · doi:10.3390/vaccines9020097 · Cited by 288 · see citing works

Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9

Zhang, H., Zhang, Y., & Yin, H. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.014 · Cited by 248 · see citing works

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives

Gómez-Aguado, I., Rodríguez-Castejón, J., Vicente-Pascual, M., Rodríguez‐Gascón, A., Solinís, M. Á., & del Pozo‐Rodríguez, A. (2020) · Nanomaterials · doi:10.3390/nano10020364 · Cited by 224 · see citing works

Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications

Jeong, M., Lee, Y., Park, J., Jung, H., & Lee, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114990 · Cited by 227 · see citing works

Imidazole‐Based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes

Zhao, X., Chen, J., Qiu, M., Li, Y., Glass, Z., & Xu, Q. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202008082 · Cited by 179 · see citing works

Recent Advancement in mRNA Vaccine Development and Applications

Fayez, N. A., Nassar, M. S., Alshehri, A. A., Alnefaie, M. K., Almughem, F. A., Alshehri, B. Y., Alawad, A. O., & Tawfik, E. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071972 · Cited by 177 · see citing works

Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy

Zheng, Y., Han, Y., Sun, Q., & Li, Z. (2022) · Exploration · doi:10.1002/exp.20210166 · Cited by 151 · see citing works

mRNA vaccine in cancer therapy: Current advance and future outlook

Li, Y., Wang, M., Peng, X., Yang, Y., Chen, Q., Liu, J., She, Q., Tan, J., Lou, C., Liao, Z., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1384 · Cited by 152 · see citing works

RNA-based scaffolds for bone regeneration: application and mechanisms of mRNA, miRNA and siRNA

Leng, Q., Chen, L., & Lv, Y. (2020) · Theranostics · doi:10.7150/thno.42640 · Cited by 146 · see citing works

Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP

Lin, Y., Wagner, E., & Lächelt, U. (2022) · Biomaterials Science · doi:10.1039/d1bm01658j · Cited by 141 · see citing works

mRNA nanomedicine: Design and recent applications

Kubiatowicz, L. J., Mohapatra, A., Krishnan, N., Fang, R. H., & Zhang, L. (2022) · Exploration · doi:10.1002/exp.20210217 · Cited by 130 · see citing works

Biomedical applications of mRNA nanomedicine

Xiong, Q., Lee, G. Y., Ding, J., Li, W., & Shi, J. (2018) · Nano Research · doi:10.1007/s12274-018-2146-1 · Cited by 125 · see citing works

Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications

Leong, K. Y., Tham, S. K., & Poh, C. L. (2025) · Virology Journal · doi:10.1186/s12985-025-02645-6 · Cited by 128 · see citing works

Machine Learning for Designing Next-Generation mRNA Therapeutics

Castillo-Hair, S. M., & Seelig, G. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00621 · Cited by 119 · see citing works

Efficient Myogenic/Adipogenic Transdifferentiation of Bovine Fibroblasts in a 3D Bioprinting System for Steak‐Type Cultured Meat Production

Jeong, D., Seo, J. W., Lee, H., Jung, W. K., Park, Y. H., & Bae, H. (2022) · Advanced Science · doi:10.1002/advs.202202877 · Cited by 111 · see citing works

Optimizing 5’UTRs for mRNA-delivered gene editing using deep learning

Castillo-Hair, S., Fedak, S., Wang, B., Linder, J., Havens, K., Certo, M., & Seelig, G. (2024) · Nature Communications · doi:10.1038/s41467-024-49508-2 · Cited by 98 · see citing works

Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications

Patel, S., Athirasala, A., Menezes, P. D. P., Ashwanikumar, N., Zou, T., Sahay, G., & Bertassoni, L. E. (2018) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0444 · Cited by 99 · see citing works

Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing

Chen, Q., Zhang, Y., & Yin, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.014 · Cited by 96 · see citing works

Synthetic modified messenger RNA for therapeutic applications

Gao, M., Zhang, Q., Feng, X.-H., & Liu, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.020 · Cited by 89 · see citing works

Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles

Chen, C.-Y., Tran, D. M., Cavedon, A., Cai, X., Rajendran, R., Lyle, M. J., Martini, P. G. V., & Miao, C. H. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.03.015 · Cited by 89 · see citing works

Future regenerative medicine developments and their therapeutic applications

Altyar, A. E., El-Sayed, A., Abdeen, A., Piscopo, M., Mousa, S. A., Najda, A., & Abdel‐Daim, M. M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114131 · Cited by 92 · see citing works

Recent progress in the manipulation of biochemical and biophysical cues for engineering functional tissues

Bakhshandeh, B., Ranjbar, N., Abbasi, A., Amiri, E., Abedi, A., Mehrabi, M., Dehghani, Z., & Pennisi, C. P. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10383 · Cited by 84 · see citing works

Tumor Associated Macrophages and TAMs‐Based Anti‐Tumor Nanomedicines

Cheng, Y., Song, S., Wu, P., Lyu, B., Qin, M., Sun, Y., Sun, A., Mu, L.-M., Xu, F., Zhang, L., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100590 · Cited by 80 · see citing works

Engineered Exosomes Loaded in Intrinsic Immunomodulatory Hydrogels with Promoting Angiogenesis for Programmed Therapy of Diabetic Wounds

Huang, W., Guo, Q., Wu, H., Zheng, Y., Xiang, T., & Zhou, S. (2025) · ACS Nano · doi:10.1021/acsnano.5c02896 · Cited by 80 · see citing works

Developing Small Activating RNA As a Therapeutic: Current Challenges and Promises

Kwok, A., Raulf, N., & Habib, N. A. (2019) · Therapeutic Delivery · doi:10.4155/tde-2018-0061 · Cited by 78 · see citing works

mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy

Sasaki, K., Sato, Y., Okuda, K., Iwakawa, K., & Harashima, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081572 · Cited by 78 · see citing works

Efficient delivery of VEGF-A mRNA for promoting diabetic wound healing via ionizable lipid nanoparticles

Zha, W., Wang, J., Guo, Z., Zhang, Y., Wang, Y., Dong, S., Liu, C., Xing, H., & Li, X. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122565 · Cited by 74 · see citing works

mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies

Chabanovska, O., Galow, A.-M., David, R., & Lemcke, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114002 · Cited by 76 · see citing works

mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles

Ouranidis, A., Vavilis, T., Mandala, E., Davidopoulou, C., Stamoula, Ε., Markopoulou, C. K., Karagianni, A., & Kachrimanis, K. (2021) · Biomedicines · doi:10.3390/biomedicines10010050 · Cited by 72 · see citing works

Hydrogel Drug Delivery Systems for Bone Regeneration

Bai, L., Tao, G., Feng, M., Xie, Y., Cai, S., Peng, S., & Xiao, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051334 · Cited by 70 · see citing works

The use of design of experiments with multiple responses to determine optimal formulations for in vivo hepatic mRNA delivery

Hashiba, A., Toyooka, M., Sato, Y., Maeki, M., Tokeshi, M., & Harashima, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.031 · Cited by 66 · see citing works

Adjuvant incorporated lipid nanoparticles for enhanced mRNA-mediated cancer immunotherapy

Lee, K., Kim, S. Y., Seo, Y., Kim, M. H., Chang, J., & Lee, H. (2019) · Biomaterials Science · doi:10.1039/c9bm01564g · Cited by 65 · see citing works

Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing

Youssef, M., Hitti, C., Fulber, J. P. C., & Kamen, A. (2023) · Biomolecules · doi:10.3390/biom13101497 · Cited by 62 · see citing works

mRNA therapies: Pioneering a new era in rare genetic disease treatment

Shen, G., Liu, J., Yang, H., Xie, N., & Yang, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.056 · Cited by 61 · see citing works

Cytidine-containing tails robustly enhance and prolong protein production of synthetic mRNA in cell and in vivo

Li, C. Y., Liang, Z., Hu, Y., Zhang, H., Setiasabda, K. D., Li, J., Ma, S., Xia, X., & Kuang, Y. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.10.003 · Cited by 58 · see citing works

Messenger RNA vaccines for cancer immunotherapy: progress promotes promise

Huff, A. L., Jaffee, E. M., & Zaidi, N. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156211 · Cited by 56 · see citing works

Self-amplifying mRNA vaccines: Mode of action, design, development and optimization

Pourseif, M. M., Masoudi‐Sobhanzadeh, Y., Azari, E., Parvizpour, S., Barar, J., Ansari, R. A., & Omidi, Y. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103341 · Cited by 54 · see citing works

Development of lipid-like materials for RNA delivery based on intracellular environment-responsive membrane destabilization and spontaneous collapse

Tanaka, H., Sakurai, Y., Anindita, J., & Akita, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.001 · Cited by 56 · see citing works

Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery

Han, G., Noh, D., Lee, H., Lee, S., Kim, S., Yoon, H. Y., & Hyeon, L. S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114973 · Cited by 52 · see citing works

An Update on mRNA-Based Viral Vaccines

Jeeva, S., Kim, K., Shin, C. H., Wang, B., & Kang, S. (2021) · Vaccines · doi:10.3390/vaccines9090965 · Cited by 49 · see citing works

Characterization of mRNA therapeutics

Guimaraes, G. J., Kim, J., & Bartlett, M. G. (2023) · Mass Spectrometry Reviews · doi:10.1002/mas.21856 · Cited by 48 · see citing works

The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods

Metanat, Y., Viktor, P., Amajd, A., Kaur, I., Hamed, A. M., Al-Abadi, N. K. A., Alwan, N. H., Chaitanya, M., Natrayan, L., Ghildiyal, P., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122683 · Cited by 48 · see citing works

The versatile applications of polydopamine in regenerative medicine: Progress and challenges

Cai, S., Cheng, Y., Qiu, C., Liu, G., & Chu, C. (2022) · Smart Materials in Medicine · doi:10.1016/j.smaim.2022.11.005 · Cited by 46 · see citing works

Therapy Development by Genome Editing of Hematopoietic Stem Cells

Koniali, L., Lederer, C. W., & Kleanthous, M. (2021) · Cells · doi:10.3390/cells10061492 · Cited by 46 · see citing works

Engineered mRNA Delivery Systems for Biomedical Applications

Wang, J., Zhu, H., Gan, J., Liang, G., Li, L., & Zhao, Y. (2023) · Advanced Materials · doi:10.1002/adma.202308029 · Cited by 44 · see citing works

Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment

Karim, M. E., Haque, S. T., Al-Busaidi, H., Bakhtiar, A., Tha, K. K., Holl, M. M. B., & Chowdhury, E. H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01418-x · Cited by 42 · see citing works

Delivery of synthetic mRNAs for tissue regeneration

Steinle, H., Weber, M., Stoppelkamp, S., Große‐Berkenbusch, K., Golombek, S., Weber, M., Çanak-Ipek, T., Trenz, S.-M., Schlensak, C., & Avci‐Adali, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114007 · Cited by 41 · see citing works

In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future

Perenkov, A. D., Sergeeva, A. D., Vedunova, M. V., & Krysko, D. V. (2023) · Vaccines · doi:10.3390/vaccines11101600 · Cited by 40 · see citing works

Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment

Ullah, A., Khan, M., Zhang, Y., Shafiq, M., Ullah, M., Abbas, A., Xianxiang, X., Chen, G., & Diao, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s429279 · Cited by 37 · see citing works

In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation

Cafferty, S. M., Temmerman, J. D., Kitada, T., Becraft, J. R., Weiss, R., Irvine, D. J., Devreese, M., Baere, S. D., Combes, F., & Sanders, N. N. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.010 · Cited by 37 · see citing works

Digital Twins for Continuous mRNA Production

Helgers, H., Hengelbrock, A., Schmidt, A., & Strube, J. (2021) · Processes · doi:10.3390/pr9111967 · Cited by 37 · see citing works

Microneedle systems for delivering nucleic acid drugs

Noh, I., Lee, K., & Rhee, Y.-S. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00558-4 · Cited by 37 · see citing works

Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules

Zhang, J., Liu, Y., Li, C., Xiao, Q., Zhang, D., Chen, Y., Rosenecker, J., Ding, X., & Guan, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092182 · Cited by 39 · see citing works

mRNA delivery via non-viral carriers for biomedical applications

Shuai, Q., Zhu, F., Zhao, M., & Yan, Y. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121020 · Cited by 35 · see citing works

Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor

Amistadi, S., Maule, G., Ciciani, M., Ensinck, M. M., Keersmaecker, L. D., Ramalho, A. S., Guidone, D., Buccirossi, M., Galietta, L. J. V., Carlon, M. S., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.03.004 · Cited by 35 · see citing works

Recent development of gene therapy for pancreatic cancer using non-viral nanovectors

Liu, Y., Wu, W., Wang, Y., Han, S., Yuan, Y., Huang, J., Shuai, X., & Peng, Z. M. (2021) · Biomaterials Science · doi:10.1039/d1bm00748c · Cited by 33 · see citing works

Opportunities and Challenges for mRNA Delivery Nanoplatforms

Zhang, Y., Hu, Y., Tian, H., & Chen, X. (2022) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c03898 · Cited by 33 · see citing works

Structural Insights into the Interaction of Clinically Relevant Phosphorothioate mRNA Cap Analogs with Translation Initiation Factor 4E Reveal Stabilization via Electrostatic Thio-Effect

Warmiński, M., Kowalska, J., Nowak, E., Kubacka, D., Tibble, R. W., Kasprzyk, R., Sikorski, P. J., Gross, J. D., Nowotny, M., & Jemielity, J. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00864 · Cited by 31 · see citing works

Development of mRNA Vaccines/Therapeutics and Their Delivery System

Son, S., & Lee, K. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2165 · Cited by 31 · see citing works

Path towards mRNA delivery for cancer immunotherapy from bench to bedside

Chen, W., Zhu, Y., He, J., & Sun, X. (2023) · Theranostics · doi:10.7150/thno.89247 · Cited by 31 · see citing works

mRNA vaccines: A novel weapon to control infectious diseases

Tian, Y., Deng, Z., & Yang, P. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1008684 · Cited by 28 · see citing works

Membrane technology for the purification of RNA and DNA therapeutics

Javidanbardan, A., Messerian, K. O., & Zydney, A. L. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.11.016 · Cited by 28 · see citing works

Nucleic acid delivery and nanoparticle design for COVID vaccines

Andresen, J. L., & Fenton, O. S. (2021) · MRS Bulletin · doi:10.1557/s43577-021-00169-2 · Cited by 29 · see citing works

Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy

Neill, B., Romero, A. R., & Fenton, O. S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00721 · Cited by 30 · see citing works

mRNA therapeutics: Transforming medicine through innovation in design, delivery, and disease treatment

Ige, M. A., Ren, X., Yang, Y., Zhang, H., Shen, C., Jiang, Y., Li, J., & Wan, X. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102721 · Cited by 29 · see citing works

Development of Lipid Nanoparticles for the Delivery of Macromolecules Based on the Molecular Design of pH-Sensitive Cationic Lipids

Sato, Y. (2021) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c21-00705 · Cited by 28 · see citing works

Mitochondrial gene editing

Shoop, W. K., Bacman, S. R., Barrera-Paez, J. D., & Moraes, C. T. (2023) · Nature Reviews Methods Primers · doi:10.1038/s43586-023-00200-7 · Cited by 33 · see citing works

Targeted LNPs deliver IL-15 superagonists mRNA for precision cancer therapy

Yu, J., Li, Q., Zhang, C., Wang, Q., Luo, S., Wang, X., Hu, R., & Cheng, Q. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123047 · Cited by 26 · see citing works

The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review

Halma, M. T. J., Rose, J., Jenks, A., & Lawrie, T. A. (2023) · J — Multidisciplinary Scientific Journal · doi:10.3390/j6020017 · Cited by 25 · see citing works

Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach

Goyal, F., Chattopadhyay, A., Navik, U., Jain, A., Reddy, P. H., Bhatti, G. K., & Bhatti, J. S. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300255 · Cited by 24 · see citing works

From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases

Pandey, M., Ojha, D., Bansal, S., Rode, A. B., & Chawla, G. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101003 · Cited by 23 · see citing works

An overview of reprogramming approaches to derive integration-free induced pluripotent stem cells for prospective biomedical applications

Dey, C., Raina, K., Haridhasapavalan, K. K., Thool, M., Sundaravadivelu, P. K., Adhikari, P., Gogoi, R., & Thummer, R. P. (2021) · Recent Advances in iPSC Technology · doi:10.1016/b978-0-12-822231-7.00011-4 · Cited by 23 · see citing works

Electrospun fiber-mediated delivery of neurotrophin-3 mRNA for neural tissue engineering applications

Puhl, D. L., Funnell, J. L., Fink, T. D., Swaminathan, A., Oudega, M., Zha, R. H., & Gilbert, R. J. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.025 · Cited by 23 · see citing works

mRNA delivery technologies: Toward clinical translation

Gómez-Aguado, I., Rodríguez-Castejón, J., Beraza-Millor, M., Rodríguez‐Gascón, A., del Pozo‐Rodríguez, A., & Solinís, M. Á. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.010 · Cited by 23 · see citing works

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progress

Li, S., Zheng, L., Zhong, J., & Gao, X. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253009 · Cited by 21 · see citing works

The clinical progress and challenges of mRNA vaccines

Yu, M., Wang, N., Zhu, J., & Lin, Y. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1894 · Cited by 22 · see citing works

mRNA Vaccine Platform: mRNA Production and Delivery

Litvinova, V. R., Рудометов, А. П., Карпенко, Л. И., & Ilyichev, A. A. (2023) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162023020152 · Cited by 21 · see citing works

Development of mRNA vaccines and their prophylactic and therapeutic applications

Lee, K., Kim, M., Seo, Y., & Lee, H. (2018) · Nano Research · doi:10.1007/s12274-018-2095-8 · Cited by 21 · see citing works

Efficient reduction of synthetic mRNA induced immune activation by simultaneous delivery of B18R encoding mRNA

Michel, T., Golombek, S., Steinle, H., Hann, L., Velić, A., Maček, B., Krajewski, S., Schlensak, C., Wendel, H. P., & Avci‐Adali, M. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0172-5 · Cited by 20 · see citing works

The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA

Taina-González, L., & de la Fuente, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020460 · Cited by 21 · see citing works

RNA nanomedicine in liver diseases

Bakrania, A. K., Mo, Y., Zheng, G., & Bhat, M. (2023) · Hepatology · doi:10.1097/hep.0000000000000606 · Cited by 20 · see citing works

Demineralized bone matrix scaffold modified with mRNA derived from osteogenically pre-differentiated MSCs improves bone repair

Leng, Q., Liang, Z., & Lv, Y. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111601 · Cited by 20 · see citing works

Unleashing the potential of mRNA therapeutics for inherited neurological diseases

Monfrini, E., Baso, G., Ronchi, D., Meneri, M., Gagliardi, D., Quetti, L., Verde, F., Ticozzi, N., Ratti, A., Fonzo, A. D., et al. (2024) · Brain · doi:10.1093/brain/awae135 · Cited by 19 · see citing works

Current Trends in Messenger RNA Technology for Cancer Therapeutics

Afzal, A., Abbasi, M. H., Ahmad, S., Sheikh, N., & Khawar, M. B. (2025) · Biomaterials Research · doi:10.34133/bmr.0178 · Cited by 21 · see citing works

Rapid DNA Repair in Mesenchymal Stem Cells and Bone Regeneration by Nanoparticle-Based Codelivery of Nrf2-mRNA and Dexamethasone

Park, J. S., Jeon, H., Lee, Y., Cheon, S. Y., Lee, D., Lim, S. G., & Koo, H. (2024) · ACS Nano · doi:10.1021/acsnano.4c08939 · Cited by 19 · see citing works

Improving the Repeatability and Efficacy of Intradermal Electroporated Self-Replicating mRNA

Huysmans, H., Temmerman, J. D., Zhong, Z., Cafferty, S. M., Combes, F., Haesebrouck, F., & Sanders, N. N. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.06.011 · Cited by 19 · see citing works

Vibration-assisted ultrafiltration dramatically improves mRNA purification

Behboudi, A., Javidanbardan, A., Wang, Z., Zhou, L., & Zydney, A. L. (2025) · Separation and Purification Technology · doi:10.1016/j.seppur.2025.132179 · Cited by 18 · see citing works

Non-Viral RNA Therapies for Non-Small Cell Lung Cancer and Their Corresponding Clinical Trials

Tiwade, P. B., Fung, V., VanKeulen‐Miller, R., Narasipura, E. A., Ma, Y., & Fenton, O. S. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00871 · Cited by 18 · see citing works

Biomaterial scaffold-based gene delivery for the repair of complex wounds: Challenges, progress, and future perspectives

Chávez, J. C. P., McGrath, M., Kearney, C. J., Browne, S., & O’Brien, F. J. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100073 · Cited by 18 · see citing works

Emerging mRNA Technology for Liver Disease Therapy

Wang, J., Fang, Y., Luo, Z., Wang, J., & Zhao, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c02987 · Cited by 19 · see citing works

Transfection of hypoxia-inducible factor-1α mRNA upregulates the expression of genes encoding angiogenic growth factors

Włodarczyk, J., Leng, A., Abadchi, S. N., Shababi, N., Mokhtari‐Esbuie, F., Gheshlaghi, S., Ravari, M. R., Pippenger, E. K., Afrasiabi, A., Ha, J. S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-54941-w · Cited by 17 · see citing works

Nucleoside modifications of in vitro transcribed mRNA to reduce immunogenicity and improve translation of prophylactic and therapeutic antigens

Alameh, M., & Weissman, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821595-1.00014-2 · Cited by 17 · see citing works

Immune microenvironment: novel perspectives on bone regeneration disorder in osteoradionecrosis of the jaws

Chen, H., Liu, Z., Yue, K., Ding, J., & He, Y. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03743-z · Cited by 17 · see citing works

Delivery of mRNA for cancer therapy: progress and prospects

Su, L.-J., Xu, M.-X., Ji, Z.-H., Zhu, J.-Q., Yu, M., Wang, Y., & Lin, Y. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102013 · Cited by 17 · see citing works

mRNA Synthesis

Brady, M. (2024) · INFM-OAR (INFN Catania) · doi:10.15161/oar.it/143676

Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges

Steinle, H., Behring, A., Schlensak, C., Wendel, H. P., & Avci‐Adali, M. (2016) · Stem Cells · doi:10.1002/stem.2402 · Cited by 78 · see citing works

mRNA: Fulfilling the Promise of Gene Therapy

Weissman, D., & Karikó, K. (2015) · Molecular Therapy · doi:10.1038/mt.2015.138 · Cited by 111 · see citing works

mRNA-based therapies: Preclinical and clinical applications

Qureischi, M., Mohr, J., Arellano-Viera, E., Knudsen, S. E., Vohidov, F., & Garitano-Trojaola, A. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.007 · Cited by 21 · see citing works

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works